🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Mounjaro savings card update — July 2024 Page 11

Mounjaro savings card update — July 2024

tammy_FL Wed, Feb 7, 2024 at 5:59 PM 60 replies 3,510 viewsPage 11 of 12
pam_columbus
Member
312
1,345
Aug 2024
Columbus, OH
Feb 17, 2024 at 5:52 AM#51
LabKate said:
If you are going to change something, change one thing and give it long enough to express itself.

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

24 22kevin_tulsa, Dr.PainCLE, mike_mealprep and 21 others
Reply Quote Save Share Report
amy_econ_NJ
Member
567
2,567
May 2024
Princeton, NJ
Feb 17, 2024 at 12:03 PM#52
LabKate said:
If you are going to change something, change one thing and give it long enough to express itself.

That reframing is the part I needed. Adding it to my notes with a link back to this thread.

Last edited: Feb 17, 2024 at 3:03 PM
25 23hannah_MT, Dr.SportsMedIN, amy_econ_NJ and 22 others
Reply Quote Save Share Report
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
Feb 17, 2024 at 6:14 PM#53

Clinical perspective, offered as context rather than as advice. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

26 24JennaRN, LabKate, kate.chem and 23 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
hannah_MT
New Member
23
89
Feb 2026
Bozeman, MT
Feb 18, 2024 at 12:25 AM#54
MASHdoc_SA said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Second this.

Last edited: Feb 18, 2024 at 3:25 AM
27 0PurityPaulOR, MaxMetOK, MounjBrad and 24 others
Reply Quote Save Share Report
LindaRN_retired
Member
189
890
Dec 2024
Sarasota, FL
Feb 18, 2024 at 6:35 AM#55
MASHdoc_SA said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Adding the part of the answer the thread has not reached. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

Last edited: Feb 18, 2024 at 9:35 AM
28 1mike_nyc, VendorMark, COA_Karl and 25 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register